24/7 Clients Support
- 24/7
Customer Service
- ISO 9001
Certification Company
- WHO-GMP
Certified Company
DOCELIEVA 20MG is an Injection medication used for treatment purposes. It is manufactured by Allieva Pharma Private Limited.
| Brand Name | DOCELIEVA 20MG |
|---|---|
| Composition | Docetaxel Injection IP 20mg |
| Manufacturer | Allieva Pharma Private Limited |
| Dosage Form | Injection |
| Packaging | Vial |
| Country of Origin | India |
Docetaxel Injection IP 20 MG (Docetaxel Injection IP 20mg) is a widely used Injection medicine manufactured by Allieva Pharma Private Limited. It is commonly prescribed for...
DOCELIEVA 20 mg contains Docetaxel, a chemotherapy (anticancer) medicine from the taxane group. It works by promoting and stabilizing microtubules, thereby preventing cancer cell division and causing cell death.
Docetaxel Injection is used in the treatment of:
Breast cancer
Non-small cell lung cancer (NSCLC)
Prostate cancer (metastatic, hormone-refractory)
Gastric (stomach) cancer
Head and neck squamous cell carcinoma
Common side effects:
Hair loss (alopecia)
Nausea, vomiting
Myelosuppression (especially neutropenia)
Fatigue and weakness
Peripheral neuropathy
Fluid retention (edema)
Mouth sores (stomatitis)
Serious side effects:
Severe neutropenia with infection risk
Hypersensitivity reactions
Severe fluid retention (pleural effusion, ascites)
Liver function abnormalities
Dosage depends on body surface area (BSA), cancer type, and regimen.
Common dosing:
75 mg/m² IV infusion every 3 weeks
100 mg/m² IV infusion every 3 weeks (in selected cases)
NOTE: This medicine should be taken only under a doctor’s supervision.